文献速递主动脉疾病

手术置入椎旁导管与开放腹主动脉瘤修复术后镇痛

Surgically positioned paravertebral catheters and postoperative analgesia after open abdominal aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2019-05-29

这项回顾性队列研究纳入2005至2016年355例择期开放腹主动脉瘤修复患者,比较全身镇痛、手术置入椎旁导管和胸段硬膜外镇痛。椎旁导管和胸段硬膜外镇痛均与术后吗啡当量消耗降低相关,椎旁导管还与更早转出重症监护相关。

要点

  • 椎旁导管和胸段硬膜外镇痛较全身镇痛显著降低术后第1至3天吗啡当量消耗。
  • 椎旁导管较全身镇痛与更早转出重症监护相关(OR 2.75,95%CI 1.17-6.45)。
  • 椎旁导管与胸段硬膜外镇痛的阿片相关不良事件发生率相似(OR 0.44,95%CI 0.08-2.44)。

核心结论

  • 椎旁导管和胸段硬膜外镇痛较全身镇痛降低开放腹主动脉瘤修复术后吗啡当量消耗。
  • 椎旁导管较全身镇痛与更早转出重症监护相关,且与胸段硬膜外镇痛的阿片相关不良事件发生率相似。

研究设计与样本

  • 回顾性队列研究,纳入2005至2016年在新斯科舍省哈利法克斯伊丽莎白二世健康科学中心择期开放腹主动脉瘤修复的患者。
  • 共355例,其中腹膜后入路177例、经腹膜入路178例;全身镇痛173例、椎旁导管117例、胸段硬膜外镇痛65例。

主要发现

  • 术后第1天吗啡当量中位数:全身镇痛984(IQR 342-1525),椎旁导管89(33-246),胸段硬膜外镇痛49(0-90)。
  • 术后第2天吗啡当量中位数:全身镇痛105(IQR 57-210),椎旁导管45(15-99),胸段硬膜外镇痛30(0-64)。
  • 术后第3天吗啡当量中位数:全身镇痛45(IQR 15-120),椎旁导管30(0-60),胸段硬膜外镇痛10(0-45)。

关键数值与推荐

  • 与全身镇痛相比,椎旁导管和胸段硬膜外镇痛增加术后第1天未接受阿片类药物的比值比分别为66.85(95%CI 17.49-255.57)和214.68(95%CI 60.20-766.38)。
  • 若接受阿片类药物,与全身镇痛相比,椎旁导管和胸段硬膜外镇痛在术后第1天的消耗相对风险分别为0.22(95%CI 0.18-0.27)和0.16(95%CI 0.12-0.20)。
  • 与全身镇痛相比,椎旁导管与更早转出重症监护相关(OR 2.75,95%CI 1.17-6.45),胸段硬膜外镇痛则不相关(OR 1.12,95%CI 0.56-2.2)。
  • 与胸段硬膜外镇痛相比,椎旁导管未增加阿片相关不良事件发生率(OR 0.44,95%CI 0.08-2.44)。

临床怎么用

  • 对于开放腹主动脉瘤修复患者,可考虑使用手术置入椎旁导管或胸段硬膜外镇痛以减少术后阿片类药物消耗。
  • 椎旁导管可能与更早转出重症监护相关,且阿片相关不良事件发生率与胸段硬膜外镇痛相似。

局限性

  • 本研究为单中心回顾性队列研究。
  • 研究结论主要基于腹膜后入路患者,需谨慎推广至其他入路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare postoperative morphine equivalent intake after open abdominal aortic aneurysm (AAA) repair among analgesic modalities: systemic analgesia (SA) only with no regional anesthesia, surgically positioned paravertebral catheter (PVC), and thoracic epidural analgesia (TEA). METHODS: This retrospective cohort study included patients undergoing elective open AAA at the Queen Elizabeth II Health Science Center, Halifax, Nova Scotia. Demographics, morphine equivalents, methods of analgesia administration, and outcomes data were collected on all patients from 2005 to 2016. Total morphine equivalent (MEQ) on postoperative days (PODs) 1, 2, and 3 were compared among patients with SA, PVC, and TEA. A multivariable zero-inflated log-linear regression was used to determine the association between analgesic modality and MEQ. Multivariable logistic regression models were used to determine associations between analgesic modality and postoperative pain, rates of discharge from intensive care within 1 day and opioid-related adverse events. RESULTS: The study cohort included 355 patients: 177 retroperitoneal and 178 transperitoneal repairs; 173 patients underwent SA, 117 PVC, and 65 TEA. On POD1, median MEQs were 984 (interquartile range [IQR], 342-1525) for SA, 89 (33-246) for PVC, and 49 (0-90) for TEA. On POD2, the median MEQs were 105 (IQR, 57-210) for SA, 45 (15-99) for PVC, and 30 (0-64) for TEA. On POD3, the median MEQs were 45 (IQR, 15-120) for SA, 30 (0-60) for PVC, and 10 (0-45) for TEA. On multivariable log-linear regression, compared with SA, PVC and TEA were associated with increased odds of receiving no opioids on POD1 (odds ratio [OR], 66.85; 95% confidence interval [CI], 17.49-255.57; and OR, 214.68; 95% CI, 60.20-766.38; respectively), POD 2 (OR, 6.97; 95% CI, 3.61-13.46; and OR, 28.73; 95% CI, 15.68-52.62; respectively), and POD 3 (OR, 3.93; 95% CI, 2.72-5.67; and OR, 4.68; 95% CI, 3.20-6.86; respectively). If patients did receive opioids, compared with SA, PVC and TEA were associated with decreased consumption on POD1 (RR, 0.22; 95% CI, 0.18-0.27; and RR, 0.16; 95% CI, 0.12-0.20; respectively), POD2 (RR, 0.50; 95% CI, 0.42-0.58; and RR, 0.46; 95% CI, 0.37-0.56; respectively), and POD3 (RR, 0.78; 95% CI, 0.66-0.93; and RR, 0.76; 95% CI, 0.63-0.93; respectively). Compared with SA, PVC was associated with earlier discharge from intensive care (OR, 2.75; 95% CI, 1.17-6.45) and TEA was not (OR, 1.12; 95% CI, 0.56-2.2). Compared with TEA, PVC was not associated with increased rate of opioid-related adverse events (OR, 0.44; 95% CI, 0.08-2.44). CONCLUSIONS: PVC and TEA are associated with decreased MEQ compared with SA. PVC is associated with earlier discharge from intensive care compared with SA and similar rates of opioid-related adverse events compared with TEA. Paravertebral analgesia appears to be a safe and effective analgesic modality in patients undergoing retroperitoneal approach for abdominal aneurysm repair.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jessula S, Atkinson L, Casey P, et al. Surgically positioned paravertebral catheters and postoperative analgesia after open abdominal aortic aneurysm repair. J Vasc Surg. 2019. PMID: 31153699. doi:10.1016/j.jvs.2019.02.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。